Valneva is pumping hard, check it out!

Valneva is developing a virus-disabled classical COVID vaccine with UK as its first client (Already 100M dosis preorder contract).

At each good news it pumps hard and then correct to the previous ATH before a new round.

By the way, be carefull as its vaccine will reach the phase I/II certification only in april. This will be a big milestone.
Fundamental AnalysisGrowthSupport and Resistance

Also on:

Disclaimer